Scientist to Watch

» infectious disease, cancer and developmental biology

Most Recent

Member, Department of Immunology, St. Jude Children’s Research Hospital. Age: 43

0 Comments

Instructor, Department of Systems Biology, University of Texas MD Anderson Cancer Center. Age: 38

1 Comment

image: Thomas Gregor: Biological Quantifier

Thomas Gregor: Biological Quantifier

By | November 1, 2013

Assistant Professor, Physics, Princeton University. Age: 39

0 Comments

image: David Sabatini: Demystifying mTOR

David Sabatini: Demystifying mTOR

By | March 1, 2012

Principal Investigator, Whitehead Institute for Biomedical Research. Associate Professor, Department of Biology, Massachusetts Institute of Technology. Age: 44

0 Comments

image: Lynne-Marie Postovit: Cancer Modeler

Lynne-Marie Postovit: Cancer Modeler

By | January 1, 2012

Assistant Professor, Department of Anatomy and Cell Biology, University of Western Ontario. Age: 34

3 Comments

image: Frank Bradke: Privy to Axon Growth

Frank Bradke: Privy to Axon Growth

By | December 1, 2011

Full Professor and Senior Research Group Leader, German Center for Neurodegenerative Diseases. Age: 42

5 Comments

image: Harmit Malik: Viral Historian

Harmit Malik: Viral Historian

By | July 1, 2011

Member, Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. Age: 38

3 Comments

image: Ted Cohen: Travelling for TB

Ted Cohen: Travelling for TB

By | March 1, 2011

Assistant professor, Department of Epidemiology, Harvard School of Public Health. Age: 37

0 Comments

image: Jeremy Reiter: Hunting for Cilia

Jeremy Reiter: Hunting for Cilia

By | January 1, 2011

Assistant professor of biochemistry, University of California, San Francisco. Age: 39

3 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

  4. Another DNA Vaccine for Zika Shows Promise
RayBiotech